Autoimmune Diagnostics IMMCO Diagnostics operates in autoimmune disease diagnostics and offers reference lab services to the US market, highlighting a potential cross sell of their assays to US clinical labs and partnerships with healthcare providers seeking specialized autoimmune testing.

Growth Opportunity With 11-50 employees and annual revenue in the 10-25 million range, IMMCO appears to be a mid-sized niche supplier positioned for channel expansion through distributors, hospital systems, and reference lab networks seeking diverse autoimmune panels.

Global Distribution The company markets diagnostics worldwide, suggesting opportunities to scale international partnerships, tolling arrangements, and contract labs in regions seeking autoimmune test platforms compatible with global clinical guidelines.

Strategic Alliances Compare with larger peers in the benchmark set to identify gaps and propose co-development or distribution partnerships, custom assay kits, or white-label options to accelerate market penetration for IMMCO’s tests.

Technology & Services Although specific tech stack details are not provided, IMMCO’s emphasis on diagnostics and reference lab services implies potential upsell of advanced instrumentation, automation, or data analytics services to improve throughput and reporting for partner labs.